Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Sales | 3,144 | 2,394 | 1,743 | 1,713 | 1,520 |
| Cost of Goods | 1,853 | 1,271 | 1,053 | 1,198 | 1,049 |
| Gross Profit | 1,291 | 1,123 | 691 | 515 | 471 |
| Operating Expenses | 1,724 | 1,118 | 897 | 969 | 851 |
| Operating Income | 420 | 276 | -153 | -256 | -331 |
| Interest Expense | 22 | 3 | 3 | 3 | 3 |
| Other Income | 0 | 0 | 1 | 215 | 1 |
| Pre-tax Income | 398 | 274 | -156 | -43 | -333 |
| Net Income Continuous | 398 | 274 | -156 | -43 | -333 |
| Net Income | $398 | $274 | $-156 | $-43 | $-333 |
| EPS Basic Total Ops | 0.01 | 0.01 | -0.01 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | 0.02 | 0.01 | -0.01 | 0.00 | -0.02 |
| EPS Diluted Total Ops | 0.01 | 0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | 0.01 | 0.01 | -0.01 | 0.00 | -0.02 |
| EBITDA(a) | $511 | $382 | $-33 | $-106 | $-213 |